New York Oncology, Hematology

Latham, New York 12210

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Colorectal Neoplasms, Non Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Rectal Neoplasms, Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• Study of PX-866 and Docetaxel in Solid Tumors — Completed
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) — Completed